Cargando…
Behavioral activation therapy for depression and anxiety in cancer patients: a case series study
BACKGROUND: Behavioral activation therapy (BAT) directly addresses activities that individuals value most highly, and may be easily applicable to cancer patients. However, there is no established evidence of the use of BAT in this population. In this study, we examined the possibility of a BAT progr...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487522/ https://www.ncbi.nlm.nih.gov/pubmed/31168316 http://dx.doi.org/10.1186/s13030-019-0151-6 |
_version_ | 1783414514844172288 |
---|---|
author | Hirayama, Takatoshi Ogawa, Yuko Yanai, Yuko Suzuki, Shin-ichi Shimizu, Ken |
author_facet | Hirayama, Takatoshi Ogawa, Yuko Yanai, Yuko Suzuki, Shin-ichi Shimizu, Ken |
author_sort | Hirayama, Takatoshi |
collection | PubMed |
description | BACKGROUND: Behavioral activation therapy (BAT) directly addresses activities that individuals value most highly, and may be easily applicable to cancer patients. However, there is no established evidence of the use of BAT in this population. In this study, we examined the possibility of a BAT program for depression and anxiety in cancer patients. CASE PRESENTATION: We retrospectively reviewed the medical records of cancer patients with each of the following characteristics: 1) were outpatients or inpatients visiting the psycho-oncology division of the National Cancer Center Hospital in Japan; 2) met criteria for Major Depressive Disorder or Adjustment Disorders; and 3) participated in a BAT program. The primary outcome was the program completion percentage. Secondary outcomes were self-reported depression severity (Patient Health Questionnaire-9 (PHQ-9) score), anxiety disorder status (Generalized Anxiety Disorder-7 (GAD-7) score), and clinical improvement (Clinical Global Impression-Improvement (CGI-I) score) after the program. We analyzed both depression and anxiety by the matched paired t-test. Ten patients participated in the program, and nine completed it. One dropped out due to cognitive impairment secondary to brain metastasis. Both the PHQ-9 scores (pre: 14.4 (SD, 6.1); post: 5.1 (SD, 5.8)) and the GAD-7 scores (pre: 11.9 (SD, 4.9); post: 4.7 (SD, 5.5)) significantly improved after the program (PHQ-9: P = 0.0014; GAD-7: P = 0.0004). CGI-I scores ranged from 1 to 3, and all subjects except the patient who dropped out improved clinically. Among the ten patients, three distinctive cases could be observed as follows. Case 1; a 45-year-old housewife with breast cancer who did not agree to take antidepressants because of concerns about the side effects achieved remission without antidepressants and began to live an active life. Case 4; a 66-year-old housewife was so shocked after endometrial cancer diagnosis that she was absent-minded and her compliance with the assigned homework was poor, therefore, her depression did not improve much. Case 9; a 62-year-old man with laryngeal cancer who had recurrent anxiety. Increased business activity, on which he put great value, gradually allowed him to be able to live his life actively without concerns. CONCLUSIONS: This study suggests that BAT would be effective for the depression and anxiety of cancer patients. |
format | Online Article Text |
id | pubmed-6487522 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-64875222019-06-05 Behavioral activation therapy for depression and anxiety in cancer patients: a case series study Hirayama, Takatoshi Ogawa, Yuko Yanai, Yuko Suzuki, Shin-ichi Shimizu, Ken Biopsychosoc Med Case Report BACKGROUND: Behavioral activation therapy (BAT) directly addresses activities that individuals value most highly, and may be easily applicable to cancer patients. However, there is no established evidence of the use of BAT in this population. In this study, we examined the possibility of a BAT program for depression and anxiety in cancer patients. CASE PRESENTATION: We retrospectively reviewed the medical records of cancer patients with each of the following characteristics: 1) were outpatients or inpatients visiting the psycho-oncology division of the National Cancer Center Hospital in Japan; 2) met criteria for Major Depressive Disorder or Adjustment Disorders; and 3) participated in a BAT program. The primary outcome was the program completion percentage. Secondary outcomes were self-reported depression severity (Patient Health Questionnaire-9 (PHQ-9) score), anxiety disorder status (Generalized Anxiety Disorder-7 (GAD-7) score), and clinical improvement (Clinical Global Impression-Improvement (CGI-I) score) after the program. We analyzed both depression and anxiety by the matched paired t-test. Ten patients participated in the program, and nine completed it. One dropped out due to cognitive impairment secondary to brain metastasis. Both the PHQ-9 scores (pre: 14.4 (SD, 6.1); post: 5.1 (SD, 5.8)) and the GAD-7 scores (pre: 11.9 (SD, 4.9); post: 4.7 (SD, 5.5)) significantly improved after the program (PHQ-9: P = 0.0014; GAD-7: P = 0.0004). CGI-I scores ranged from 1 to 3, and all subjects except the patient who dropped out improved clinically. Among the ten patients, three distinctive cases could be observed as follows. Case 1; a 45-year-old housewife with breast cancer who did not agree to take antidepressants because of concerns about the side effects achieved remission without antidepressants and began to live an active life. Case 4; a 66-year-old housewife was so shocked after endometrial cancer diagnosis that she was absent-minded and her compliance with the assigned homework was poor, therefore, her depression did not improve much. Case 9; a 62-year-old man with laryngeal cancer who had recurrent anxiety. Increased business activity, on which he put great value, gradually allowed him to be able to live his life actively without concerns. CONCLUSIONS: This study suggests that BAT would be effective for the depression and anxiety of cancer patients. BioMed Central 2019-04-29 /pmc/articles/PMC6487522/ /pubmed/31168316 http://dx.doi.org/10.1186/s13030-019-0151-6 Text en © The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Case Report Hirayama, Takatoshi Ogawa, Yuko Yanai, Yuko Suzuki, Shin-ichi Shimizu, Ken Behavioral activation therapy for depression and anxiety in cancer patients: a case series study |
title | Behavioral activation therapy for depression and anxiety in cancer patients: a case series study |
title_full | Behavioral activation therapy for depression and anxiety in cancer patients: a case series study |
title_fullStr | Behavioral activation therapy for depression and anxiety in cancer patients: a case series study |
title_full_unstemmed | Behavioral activation therapy for depression and anxiety in cancer patients: a case series study |
title_short | Behavioral activation therapy for depression and anxiety in cancer patients: a case series study |
title_sort | behavioral activation therapy for depression and anxiety in cancer patients: a case series study |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487522/ https://www.ncbi.nlm.nih.gov/pubmed/31168316 http://dx.doi.org/10.1186/s13030-019-0151-6 |
work_keys_str_mv | AT hirayamatakatoshi behavioralactivationtherapyfordepressionandanxietyincancerpatientsacaseseriesstudy AT ogawayuko behavioralactivationtherapyfordepressionandanxietyincancerpatientsacaseseriesstudy AT yanaiyuko behavioralactivationtherapyfordepressionandanxietyincancerpatientsacaseseriesstudy AT suzukishinichi behavioralactivationtherapyfordepressionandanxietyincancerpatientsacaseseriesstudy AT shimizuken behavioralactivationtherapyfordepressionandanxietyincancerpatientsacaseseriesstudy |